HBM BioVentures et al. exit PharmaSwiss

Up to 97% of the purchase price will be paid at closing and the rest after escrow releases.

PharmaSwiss SA is based in Zug, Switzerland, and saw turnover of €180m in 2010. The pharmaceutical group offers products in seven therapeutic areas and operates in 19 countries throughout Central and Eastern Europe, including Poland, Hungary, the Czech Republic and Serbia. The company also has facilities in Greece and Israel and currently employs 750 people.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Diana Petrowicz on +44 20 7004 7505 or diana.petrowicz@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Exits